Complement 5a Receptor Antagonist class drugs

1 result
ChemoCentryx, Inc.
Usage: TAVNEOS is indicated as an adjunctive treatment for adult patients with severe active ANCA-associated vasculitis (specifically granulomatosis with polyangiitis and microscopic polyangiitis) in combination with standard therapy, including glucocorticoids, but does not replace glucocorticoid use.